Can Hikma Pharmaceuticals (LSE:HIK) keep its momentum this week after reaffirming its outlook?

Can Hikma Pharmaceuticals (LSE:HIK) keep its momentum this week after reaffirming its outlook? →

Highlights A routine share capital notice landed as the new trading month opened Management has reiterated its outlook following a steady recent reporting period Injectables, branded medicines and generics continue to pull in different but…